Biomotum
Portland, US · Founded 2019 · Delaware corporation · 3 known investors
Biomotum develops wearable robotic systems for gait rehabilitation that assist individuals with neurological impairments such as cerebral palsy and stroke. The technology is designed for clinical use and aims to improve walking function and patient mobility outcomes.
Founders & leadership
Biomotum was founded in 2019 by RAYMOND C BROWNING, ZACHARY L LERNER, and Ray Browning.
Investors · 3
Reported raises · per SEC filings
Form D private placements$860K disclosed across 2 rounds · 2020–2022
▶$200KraisedMar 2022 · 2 investors · Other TechnologyRule 506(b)
▶$200KraisedMar 2022 · 2 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Zachary L. LernerExecutive Officer, Director
- Raymond C. BrowningExecutive Officer, Director
- Offering amount
- $1.5M
- Amount sold
- $200K
- First sale
- Mar 2022
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
▶$660KraisedNov 2020 · 3 investors · Other TechnologyRule 506(b)
▶$660KraisedNov 2020 · 3 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- RAYMOND C BROWNINGExecutive Officer, Director, Promoter
- ZACHARY L LERNERExecutive Officer, Director, Promoter
- Offering amount
- $1M
- Amount sold
- $660K
- Minimum investment
- $25K
- First sale
- Oct 2020
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 7
by search overlap
Bioptimus8 shared keywordsBioptimus is an AI-first biotech company developing a universal AI foundation model that connects biology across scales, from molecules and cells to tissues and whole organisms, to support biomedical research and innovation. It applies machine learning to areas such as computational pathology, genomics, and drug discovery.
Ekso Bionics7 shared keywordsEkso Bionics develops wearable exoskeleton robotics used to help people with paralysis stand and walk, to augment worker physical capabilities, and to support rehabilitation and R&D. It serves medical/rehabilitation and industrial markets in the healthcare robotics and medical device category.
Hypershell Global5 shared keywordsHypershell builds wearable exoskeletons that assist walking, hiking, climbing, and cycling by reducing physical exertion and heart rate over long distances and steep terrain. Its products target outdoor adventurers, hikers, and expedition guides, and it is presented as the first exoskeleton to undergo third-party validation of its performance claims.
bio5 shared keywordsThe Biotechnology Innovation Organization (BIO) is an advocacy organization representing biotech companies, industry leaders, and state biotech associations across the United States and more than 35 countries. It provides members with policy advocacy, cost-saving programs, educational webinars, and organizes the BIO International Convention and other industry conferences.
German Bionic5 shared keywordsGerman Bionic develops wearable exoskeletons and smart power suits that use AI to assist workers with heavy lifting, prevent posture injuries, and improve workplace safety. The company serves industrial, logistics, healthcare, and airport operations sectors globally.
Bioventus4 shared keywordsBioventus develops orthobiologics and pain treatment products for orthopedic care, offering therapies such as the StimRouter neurostimulation device for chronic peripheral nerve pain. Its portfolio serves patients, physicians, and payers in the medical device and healing space.
Mammoth Biosciences4 shared keywordsMammoth Bio develops technology to read and write the code of life, operating in the biotechnology sector.
Companies competing with Biomotum for the same Google search keywords, organic and paid, via search-intersection analysis.
Non-dilutive funding · 3 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase ISTTR | 2023 | $274.3K |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2021 | $1.7M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2020 | $298.4K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does Biomotum do?
- Biomotum develops wearable robotic systems for gait rehabilitation that assist individuals with neurological impairments such as cerebral palsy and stroke. The technology is designed for clinical use and aims to improve walking function and patient mobility outcomes.
- Who founded Biomotum?
- Biomotum was founded by RAYMOND C BROWNING, ZACHARY L LERNER, Ray Browning in 2019.
- Who are Biomotum's investors?
- Biomotum's investors include Creative Destruction Lab (CDL), Portland Seed Fund, Elevate Capital.
- How much funding has Biomotum raised?
- Biomotum has disclosed $860K raised across 2 rounds.
- Where is Biomotum headquartered?
- Biomotum is headquartered in Portland, US.